| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
70.1% |
| Subacute Sclerosing Panencephalitis |
3.9% |
| Completed Suicide |
3.4% |
| Anxiety |
2.9% |
| Bipolar Disorder |
2.9% |
| Autism |
2.5% |
| Convulsion |
2.5% |
| Epilepsy |
2.0% |
| Pyrexia |
2.0% |
| Pain |
1.5% |
| Schizophrenia |
1.5% |
| Depression |
1.0% |
| Hypertension |
1.0% |
| Psychotic Disorder |
1.0% |
| Drug Use For Unknown Indication |
0.5% |
| Drug Abuse |
0.5% |
| Lung Neoplasm Malignant |
0.5% |
| Sedation |
0.5% |
|
| Toxicity To Various Agents |
36.0% |
| Poisoning |
12.0% |
| Respiratory Arrest |
10.0% |
| Exposure Via Ingestion |
4.0% |
| Renal Failure Acute |
4.0% |
| Tremor |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Completed Suicide |
2.0% |
| Hepatitis |
2.0% |
| Irritability |
2.0% |
| Medication Error |
2.0% |
| Overdose |
2.0% |
| Pain |
2.0% |
| Psychotic Disorder |
2.0% |
| Rash |
2.0% |
| Small Intestinal Obstruction |
2.0% |
| Somnolence |
2.0% |
| Spina Bifida |
2.0% |
| Suicidal Ideation |
2.0% |
| Suicide Attempt |
2.0% |
|
| Concomitant |
| Multiple Sclerosis |
21.5% |
| Product Used For Unknown Indication |
17.4% |
| Depression |
11.1% |
| Plasma Cell Myeloma |
6.9% |
| Constipation |
5.6% |
| Hypertension |
4.9% |
| Major Depression |
4.2% |
| Hepatitis C |
3.5% |
| Chronic Myeloid Leukaemia |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Epilepsy |
2.8% |
| Relapsing-remitting Multiple Sclerosis |
2.8% |
| Tuberous Sclerosis |
2.8% |
| Convulsion |
2.1% |
| Immunodeficiency Common Variable |
2.1% |
| Anxiety |
1.4% |
| Diuretic Therapy |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Gait Disturbance |
1.4% |
| Infantile Spasms |
1.4% |
|
| Vomiting |
15.4% |
| Toxicity To Various Agents |
9.0% |
| Diarrhoea |
6.4% |
| Drug Ineffective |
6.4% |
| Tremor |
6.4% |
| Weight Increased |
6.4% |
| Nausea |
5.1% |
| Vision Blurred |
5.1% |
| Weight Decreased |
5.1% |
| Headache |
3.8% |
| Rash |
3.8% |
| Somnolence |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Urinary Tract Infection |
3.8% |
| Convulsion |
2.6% |
| Death |
2.6% |
| Hypophagia |
2.6% |
| Macular Oedema |
2.6% |
| Meningitis Aseptic |
2.6% |
| Off Label Use |
2.6% |
|
